Literature DB >> 31353001

The potential of heart transplantation from donation after circulatory death donors within the United Kingdom.

Simon Messer1, Aravinda Page1, Sally Rushton2, Marius Berman1, Steven Tsui1, Pedro Catarino1, Stephen R Large1.   

Abstract

Year:  2019        PMID： 31353001     DOI： 10.1016/j.healun.2019.04.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  4 in total

Review 1.  Normothermic Regional Perfusion is an Emerging Cost-Effective Alternative in Donation After Circulatory Death (DCD) in Heart Transplantation.

Authors:  Emad Alamouti-Fard; Pankaj Garg; Ishaq J Wadiwala; John H Yazji; Mohammad Alomari; Md Walid Akram Hussain; Mohamed S Elawady; Samuel Jacob
Journal:  Cureus       Date:  2022-06-29

2.  Transplantation of a heart donated after circulatory death via thoraco-abdominal normothermic regional perfusion and results from the first Spanish case.

Authors:  Marina Pérez Redondo; Sara Alcántara Carmona; Susana Villar García; Alberto Forteza Gil; Héctor Villanueva Fernández; Francisco José Hernández-Pérez; José Luis Campo-Cañaveral de la Cruz; Rocío Velasco Calvo; Javier Segovia-Cubero; Beatriz Alonso Menárguez; Francisco Del Río Gallegos; Elisabeth Coll; Beatriz Domínguez-Gil González; Juan José Rubio Muñoz
Journal:  J Cardiothorac Surg       Date:  2020-11-25       Impact factor: 1.637

3.  Assessment of machine perfusion conditions for the donation after circulatory death heart preservation.

Authors:  Renee Cholyway; Oluwatoyin Akande; Adolfo Gabriele Mauro; Eleonora Mezzaroma; Rui Wang; Kristine Kenning; Stefano Toldo; Mohammed Quader
Journal:  Artif Organs       Date:  2022-02-22       Impact factor: 2.663

4.  Waiting list mortality and the potential of donation after circulatory death heart transplantations in the Netherlands.

Authors:  S Roest; S E Kaffka Genaamd Dengler; V van Suylen; N P van der Kaaij; K Damman; L W van Laake; J A Bekkers; M Dalinghaus; M E Erasmus; O C Manintveld
Journal:  Neth Heart J       Date:  2020-11-06       Impact factor: 2.380
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.